Marimed Inc.
MRMD- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001522767
No open-market purchases or sales by Marimed Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $45.2K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Marimed Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Marimed Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Shaw Timothy | Chief Operating Officer | 9,454,600 | Sep 1, 2026 | 11 |
| Levine Jon R | President and CEO | 21,358,631 | Jul 17, 2026 | 13 |
| Crandall Ryan | Chief Commercial Officer | 1,124,246 | Jul 17, 2026 | 11 |
| Pinho Mario | Chief Financial Officer | 335,172 | Jul 17, 2026 | 6 |
| Selhub Eva M.D. | Director | 730,748 | Jul 17, 2026 | 5 |
| Allen David R | Director | 743,452 | Jul 17, 2026 | 5 |
| Gildea Edward J | Director | 1,172,516 | Jul 17, 2026 | 5 |
| Tucker Kathleen | Director | 350,000 | Jun 6, 2025 | 0 |
| Villare Susan M. | Chief Financial Officer | – | Mar 14, 2023 | 0 |
| Fireman Robert N | President and CEO | 23,581,992 | Oct 31, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing)4:30 PM ET | May 22 | 4 days | Levine Jon RPresident and CEO | PPurchase | +60.0K | $0.0749 | +$4.50K | +0.3%21.3M after | 3 lots |
| May 20, 2026 (view filing)4:07 PM ET | May 20 | Same day | Levine Jon RPresident and CEO | PPurchase | +40.0K | $0.075 | +$3.00K | +0.2%21.2M after | |
| Dec 16, 2025 (view filing)4:23 PM ET | Dec 12 | 4 days | Shaw TimothyChief Operating Officer | PPurchase | +45.5K | $0.1071 | +$4.87K | +0.5%9.24M after | |
| Apr 29, 2024 (view filing)7:07 PM ET | Apr 29 | Same day | Shaw TimothyChief Operating Officer | SSale | −40.2K | $0.2553 | −$10.3K | −0.5%8.55M after | 10b5-1 |
| Apr 29, 2024 (view filing)5:36 PM ET | Apr 29 | Same day | Levine Jon RPresident and CEO | SSale | −50.0K | $0.2553 | −$12.8K | −0.2%20.3M after | 10b5-1 |
| Mar 11, 2024 (view filing)5:30 PM ET | Mar 7 | 4 days | Shaw TimothyChief Operating Officer | SSale | −15.3K | $0.2348 | −$3.60K | −0.2%8.48M after | 10b5-1 |
| Mar 11, 2024 (view filing)5:05 PM ET | Mar 7 | 4 days | Levine Jon RPresident and CEO | SSale | −16.5K | $0.2348 | −$3.88K | −0.1%20.2M after | 10b5-1 |
| Oct 30, 2023 (view filing)5:24 PM ET | Oct 27 | 3 days | Levine Jon RPresident and CEO | SSale | −41.6K | $0.321 | −$13.4K | −0.2%20.2M after | |
| Oct 30, 2023 (view filing)5:17 PM ET | Oct 27 | 3 days | Shaw TimothyChief Operating Officer | SSale | −33.3K | $0.321 | −$10.7K | −0.4%8.45M after | |
| May 1, 2023 (view filing)8:16 PM ET | Apr 28 | 3 days | Shaw TimothyChief Operating Officer | SSale | −39.4K | $0.3678 | −$14.5K | −0.5%8.37M after | |
| May 1, 2023 (view filing)7:59 PM ET | Apr 28 | 3 days | Levine Jon RPresident and CEO | SSale | −49.4K | $0.3768 | −$18.6K | −0.2%20.1M after |